The modern preventative treatment of recurrent miscarriage

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 103, Issue 2, 1996, Pages 106-110

  Rai, Raj ^a   Clifford, Katy ^a   Regan, Lesley ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; HEPARIN;

AUTOIMMUNITY; ENDOCRINE DISEASE; FEMALE; HUMAN; IDIOPATHIC DISEASE; IMMUNOTHERAPY; INFECTION; PRIORITY JOURNAL; REVIEW; SPONTANEOUS ABORTION;

ABORTION, HABITUAL; FEMALE; HUMANS; PREGNANCY; RISK FACTORS;

EID: 0030021959     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.1996.tb09658.x     Document Type: Review

References (41)

1. Fritz MA. Inadequate luteal function and recurrent abortion. Semin Reprod Endocrinol 1988; 6: 129–143.
2. Baird DD, Weinberg CR, Wilcox AJ, McConnaughey DR, Musey PI, Collins DC. Hormonal profiles of natural conception cycles ending in early, unrecognized pregnancy loss. J Clin Endocrinol Metab 1991; 72: 793–800.
3. Goldstein P, Berrier J, Rosen S, Sacks HS, Chalmers TC. A meta-analysis of randomized control trials of progestational agents in pregnancy. Br J Obstet Gynaecol 1989; 96: 265–274.
4. Mills JL, Simpson JL, Driscoll SG et al. Incidence of spontaneous abortion among normal women and insulin-dependent diabetic, women whose pregnancies were identified within 21 days of conception. N Engl J Med 1988; 319: 1617–1623.
5. Glinoer D, Soto MF, Bourdoux P et al. Pregnancy in patients with mild thyroid abnormalities: maternal and neonatal repercussions. J Clin Endocrinol Metab 1991; 73: 421–427.
6. Stagnaro, Green A, Roman SH, Cobin RH, el Harazy, E, Alvarez, Marfany M, Davies TF. Detection of at-risk pregnancy by means of highly sensitive assays for thyroid autoantibodies. JAMA 1990; 264: 1422–1425.
7. Lejeune B, Grun JP, de Nayer P, Servais G, Glinoer D. Antithyroid antibodies underlying thyroid abnormalities and miscarriage or pregnancy induced hypertension. Br J Obstet Gynaecol 1993; 100: 669–672.
8. Hamilton, Fairley D, Kiddy D, Watson H, Sagle M, Franks S. Low-dose gonadotrophin therapy for induction of ovulation in 100 women with polycystic ovary syndrome. Hum Reprod 1991; 6: 1095–1099.
9. Homburg R, Armar NA, Eshel A, Adams J, Jacobs HS. Influence of serum luteinising hormone concentrations on ovulation, conception, and early pregnancy loss in polycystic ovary syndrome. BMJ 1988; 297: 1024–1026.
10. Howles CM, Macnamee MC, Edwards RG, Goswamy R, Steptoe PC. Effect of high tonic levels of luteinising hormone on outcome of in–vitro fertilisation [letter]. Lancet 1986; 2: 521–522.
11. Regan L, Owen EJ, Jacobs HS. Hypersecretion of luteinising hormone, infertility, and miscarriage. Lancet 1990; 336: 1141–1144.
12. Clifford K, Rai R, Watson H, Regan L. An informative protocol for the investigation of recurrent miscamage: preliminary experience of 500 consecutive cases. Hum Reprod 1994; 9: 1328–1332.
13. Stray, Pedersen B, Stray, Pedersen S. Etiologic factors and subsequent reproductive performance in 195 couples with a prior history of habitual abortion. Am J Obster Gynecol 1984; 148: 140–146.
14. De Braekeleer M, Dao TN. Cytogenetic studies in couples experiencing repeated pregnancy losses. Hum Reprod 1990; 5: 519–528.
15. Hay PE, Lamont RF, Taylor, Robinson D, Morgan DJ, Ison C, Pearson J. Abnormal bacterial colonisation of the genital tract and subsequent preterm delivery and late miscarriage. BMJ 1994; 308: 295–298.
16. Kurki T, Sivonen A, Renkonen OV, Savia E, Ylikorkala O. Bacterial vaginosis in early pregnancy and pregnancy outcome. Obstet Gynecol 1992; 80: 173–177.
17. Simon C, Martinez L, Pardo F, Tortajada M, Pellicer A. Mullerian defects in women with normal reproductive outcome. Fertil Steril 1991; 56: 1192–1193.
18. Bennett MJ. Congenital abnormalities of the fundus. In: Bennett MJ, Edmonds DK, editors. Spontaneous and recurrent abortion. Oxford: Blackwell Scientific Publications, 1987: 109–129.
19. MRC/RCOG Working Party on Cervical Cerclage. Final report of the Medical Research Council/Royal College of Obstetricians and Gynaecologists multicentre randomised trial of cervical cerclage. Br J Obstet Gynuecol 1993; 100: 516–523.
20. Harris EN. Syndrome of the black swan. Br J Rheumatol 1987; 26: 324–326.
21. Hughes GR. Thrombosis, abortion, cerebral disease, and the lupus anticoagulant [editorial]. BMJ 1983; 287: 1088–1089.
22. Pattison NS, Chamley LW, McKay EJ, Liggins GC, Butler WS. Antiphospholipid antibodies in pregnancy: prevalence and clinical associations. Br J Obster Gynaecol 1993; 100: 909–913.
23. Rai RS, Regan L, Clifford K et al. Antiphospholipid antibodies and beta 2 glycoprotein-I in 500 women with recurrent miscarriage: results of a comprehensive screening approach. Hum Reprod 1995; 10: 2001–2005.
24. Lockwood CJ, Romero R, Feinberg RF, Clyne LP, Coster B, Hobbins JC. The prevalence and biologic significance of lupus anticoagulant and anticardiolipin antibodies in a general obstetric population. Am J Obster Gynecol 1989; 161: 369–373.
25. Perez MC, Wilson WA, Brown HL, Scopelitis E. Anticardiolipin antibodies in unselected pregnant women in relationship to fetal outcome. J Perinatol 1991; 11: 33–36.
26. Rai RS, Clifford K, Cohen H, Regan L. High prospective fetal loss rate in untreated pregnancies of women with recurrent miscarriage and antiphospholipid antibodies. Hum Reprod 1995; 10. In press.
27. De Wolf F, Carreras LO, Moerman P, Vermylen J, van Assche A, Renaer M. Decidual vasculopathy and extensive placental infarction in a patient with repeated thromboembolic accidents, recurrent fetal loss, and a lupus anticoagulant. Am J Obster Gynecol 1982; 142: 829–834.
28. Out HJ, Kooijman CD, Bruinse HW, Derksen RH. Histo-pathological findings in placentae from patients with intra-uterine fetal death and anti-phospholipid antibodies. Eur J Obsret Gynecol Reprod Biol 1991; 41: 119–186.
29. Sthoeger ZM, Mozes E, Tartakovsky B. Anticardiolipin antibodies induce pregnancy failure by impairing embryonic implantation. Proc Natl Acad Sci USA 1993; 90: 6464–6467.
30. Balasch J, Carmona F, Lopez, Soto A et al. Low-dose aspirin for prevention of pregnancy losses in women with primary antihospholipid syndrome. Hum Reprod 1993; 8: 2234–2239.
31. Cowchock FS, Reece EA, Balaban D, Branch DW, Plouffe L. Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomized trial comparing prednisone with low-dose heparin treatment. Am J Obsrer Gynecol 1992; 166: 1318–1323.
32. Lockshin MD, Druzin ML, Qamar T. Prednisone does not prevent recurrent fetal death in women with antiphospholipid antibody. Am J Obsrer Gynecol 1989; 160: 439–443.
33. Orvieto R, Achiron A, Ben, Rafael Z, Achiron R. Intravenous immunoglobulin treatment for recurrent abortions caused by antiphospholipid antibodies. Ferril Steril 1991; 56: 1013–1020.
34. Rosove MH, Tabsh K, Wasserstrum N, Howard P, Hahn BH, Kalunian KC. Heparin therapy for pregnant women with lupus anticoagulant or anticardiolipin antibodies. Obsret Gynecol 1990; 75: 630–634.
35. Silver RK, MacGregor SN, Sholl JS, Hobart JM, Neerhof MG, Ragin A. Comparative trial of prednisone plus aspirin versus aspirin alone in the treatment of anticardiolipin antibody-positive obstetric patients. Am J Obsrer Gynecol 1993; 169: 1411–1417.
36. Adinolfi M. Recurrent habitual abortion, HLA sharing and deliberate immunisation with partner's cells: a controversial topic. Hum Reprod 1986; 1: 45–48.
37. Christiansen OB, Riisom K, Lauritsen JG, Grunnet N. No increased histocompatibility antigen-sharing in couples with idiopathic habitual abortions. Hum Reprod 1986; 4: 160–162.
38. Mowbray JF, Gibbings C, Liddell H, Reginald PW, Underwood JL, Beard RW. Controlled trial of treatment of recurrent spontaneous abortion by immunisation with paternal cells. Lancet 1985; 1: 941–943.
39. Regan L, Braude PR, Hill DP. A prospective study of the incidence, time of appearance and significance of anti-paternal lymphocytotoxic antibodies in human pregnancy. Hum Reprod 1991: 6: 294–298.
40. The Recurrent Miscarriage Immunotherapy Trialists Group. Worldwide collaborative observational study and meta-analysis on allogenic leukocyte immunotherapy for recurrent spontaneous abortion. Am J Reprod Immunol 1994; 32: 55–112.
41. Mowbray JF, Underwood JL. Abstracts of contributors' individual data submitted to the worldwide prospective observation study on immunotherapy for treatment of recurrent spontaneous abortion. Am J Reprod Immunol 1994; 32: 261–274.